COVID-19 testing problems started early, U.S. still playing from behind
On Jan. 31, a little more than two weeks after COVID-19 hit the U.S., the Trump administration declared a public health emergency. Four days later, the FDA gave a Centers for Disease Control and Prevention test an emergency use authorization.
We fell behind the curve from the beginning,” said Harry Glorikian a general partner at New Ventures Funds, a venture capital firm that invests in therapeutics, precision medicine, diagnostics, and technology companies
To read the full article click on the link below: